Prospective Multicenter Evaluation of Hepatocellular Carcinoma Surveillance under American Association for the Study of Liver Diseases Version 2023 Guidance

Key Points

• This research evaluates the effectiveness of AASLD 2023 guidelines for hepatocellular carcinoma surveillance.
• Conducted a multicenter evaluation using the AASLD 2023 guidelines.
• Assessed sensitivity and negative predictive value of the new guidelines against previous versions.
• Included parameters such as visualization score, alpha-fetoprotein levels, and lesion growth.
• AASLD 2023 guidelines showed improved sensitivity and negative predictive value.
• Outperformed US Liver Imaging Reporting System 2017 and AASLD version 2018 in detection.
• Effective in identifying hepatocellular carcinoma in patients.